Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
Open Access
- 21 March 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 38 (5) , 349-361
Abstract
The benefit of the β1-adrenergic receptor (β1-AR) agonist dobutamine for treatment of acute heart failure in peripartum cardiomyopathy (PPCM) is controversial. Cardiac STAT3 expression is reduced in PPCM patients. Mice carrying a cardiomyocyte-restricted deletion of STAT3 (CKO) develop PPCM. We hypothesized that STAT3-dependent signalling networks may influence the response to β-AR agonist treatment in PPCM patients and analysed this hypothesis in CKO mice. Follow-up analyses in 27 patients with severe PPCM (left ventricular ejection fraction ≤25%) revealed that 19 of 20 patients not obtaining dobutamine improved cardiac function. All seven patients obtaining dobutamine received heart transplantation (n = 4) or left ventricular assist devices (n = 3). They displayed diminished myocardial triglyceride, pyruvate, and lactate content compared with non-failing controls. The β-AR agonist isoproterenol (Iso) induced heart failure with high mortality in postpartum female, in non-pregnant female and in male CKO, but not in wild-type mice. Iso induced heart failure and high mortality in CKO mice by impairing fatty acid and glucose uptake, thereby generating a metabolic deficit. The latter was governed by disturbed STAT3-dependent signalling networks, microRNA-199a-5p, microRNA-7a-5p, insulin/glucose transporter-4, and neuregulin/ErbB signalling. The resulting cardiac energy depletion and oxidative stress promoted dysfunction and cardiomyocyte loss inducing irreversible heart failure, which could be attenuated by the β1-AR blocker metoprolol or glucose-uptake-promoting drugs perhexiline and etomoxir. Iso impairs glucose uptake, induces energy depletion, oxidative stress, dysfunction, and death in STAT3-deficient cardiomyocytes mainly via β1-AR stimulation. These cellular alterations may underlie the dobutamine-induced irreversible heart failure progression in PPCM patients who frequently display reduced cardiac STAT3 expression.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (Hi 842/9-1, C.M., BO3643/3-1 to I.B.)
- Rebirth II
- Nieders. Volkswagenstiftung
- HomFor
- Academy of Finland, University of Turku, Turku University Hospital and Åbo Akademi University
This publication has 25 references indexed in Scilit:
- Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathyBasic Research in Cardiology, 2013
- miRNA-93 Inhibits GLUT4 and Is Overexpressed in Adipose Tissue of Polycystic Ovary Syndrome Patients and Women With Insulin ResistanceDiabetes, 2013
- MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathyJournal of Clinical Investigation, 2013
- Mitofusin 2-Containing Mitochondrial-Reticular Microdomains Direct Rapid Cardiomyocyte Bioenergetic Responses Via Interorganelle Ca 2+ CrosstalkCirculation Research, 2012
- Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivityProceedings of the National Academy of Sciences, 2012
- Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathyEuropean Journal of Heart Failure, 2010
- Elevated Cytosolic Na + Increases Mitochondrial Formation of Reactive Oxygen Species in Failing Cardiac MyocytesCirculation, 2010
- A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum CardiomyopathyCell, 2007
- Neuregulins Mediate Calcium-induced Glucose Transport during Muscle ContractionJournal of Biological Chemistry, 2006
- Evaluation of the contributions of ADAMs 9, 12, 15, 17, and 19 to heart development and ectodomain shedding of neuregulins β1 and β2Developmental Biology, 2005